Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin vs pravastatin with aromatase inhibitors in postmenopausal hormone receptor-positive early breast cancer
ChiCTR2000034035Phase 4Not yet recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in breast cancer and dyslipidemia comparing Lipophilic statin (simvastatin) arm with Hydrophilic statin (pravastatin) arm (2 arms). Primary endpoint: 5-year relapse-free survival. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
simvastatinpravastatin
03
Conditions
breast cancerdyslipidemia
Beyond the preview
Go deeper on ChiCTR2000034035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034035.